PERSONAL CFO SOLUTIONS, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
PERSONAL CFO SOLUTIONS, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$111,000
-51.9%
63,165
-11.2%
0.02%
-48.8%
Q4 2021$231,000
-36.2%
71,165
-21.1%
0.04%
-41.9%
Q3 2021$362,000
+182.8%
90,165
+15.4%
0.07%
+184.6%
Q2 2021$128,000
-14.1%
78,1650.0%0.03%
-18.8%
Q1 2021$149,000
-9.7%
78,165
+6.8%
0.03%
-22.0%
Q4 2020$165,00073,165
-17.0%
0.04%
Q3 2020$0
-100.0%
88,165
+17.3%
0.00%
-100.0%
Q2 2020$157,000
+55.4%
75,165
+17.1%
0.05%
+27.8%
Q1 2020$101,00064,1650.04%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 2,664,400$2,345,0002.45%
Key Client Fiduciary Advisors, LLC 1,120,943$986,0000.89%
Knott David M Jr 900,000$792,0000.33%
ACT CAPITAL MANAGEMENT, LLC 265,000$233,0000.32%
Perceptive Advisors 7,472,148$6,575,0000.19%
Tri Locum Partners LP 711,798$626,0000.17%
683 Capital Management, LLC 2,265,000$1,993,0000.15%
Artal Group S.A. 4,000,000$3,520,0000.15%
TANG CAPITAL MANAGEMENT LLC 1,250,000$1,100,0000.14%
HealthCor Management, L.P. 1,066,689$939,0000.12%
View complete list of LEAP THERAPEUTICS INC shareholders